MINCHIOTTI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 2.837
AS - Asia 2.204
EU - Europa 1.995
SA - Sud America 261
AF - Africa 19
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.320
Nazione #
US - Stati Uniti d'America 2.778
CN - Cina 1.343
IE - Irlanda 477
SG - Singapore 427
UA - Ucraina 364
DE - Germania 281
BR - Brasile 220
FI - Finlandia 218
HK - Hong Kong 205
RU - Federazione Russa 194
GB - Regno Unito 113
IT - Italia 108
SE - Svezia 90
VN - Vietnam 85
FR - Francia 56
JP - Giappone 31
CA - Canada 27
CZ - Repubblica Ceca 27
IN - India 24
MX - Messico 23
PL - Polonia 21
BD - Bangladesh 19
AR - Argentina 14
TR - Turchia 14
BE - Belgio 13
ES - Italia 10
EC - Ecuador 9
IQ - Iraq 8
NL - Olanda 8
CO - Colombia 7
ZA - Sudafrica 7
AZ - Azerbaigian 6
PK - Pakistan 6
PE - Perù 5
ID - Indonesia 4
MA - Marocco 4
AT - Austria 3
IR - Iran 3
JO - Giordania 3
LT - Lituania 3
MU - Mauritius 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 7.320
Città #
Dublin 476
Chandler 467
Jacksonville 439
Nanjing 308
Beijing 243
Hong Kong 205
Singapore 193
Ashburn 189
Dallas 161
Boardman 145
Nanchang 104
Changsha 92
Princeton 92
Lawrence 89
Hebei 83
Jiaxing 78
Shenyang 76
Wilmington 66
Los Angeles 64
Medford 62
Ann Arbor 61
Munich 53
Dearborn 51
Shanghai 45
Tianjin 45
Hangzhou 44
Helsinki 34
Buffalo 33
New York 30
Tokyo 30
Ho Chi Minh City 29
Redondo Beach 29
Milan 28
Woodbridge 28
Brno 26
Moscow 25
Piscataway 24
Verona 23
Norwalk 21
Warsaw 19
Hanoi 18
São Paulo 17
The Dalles 16
Houston 15
Brussels 13
Kunming 13
Turku 13
Orem 11
Boston 9
Chennai 9
Denver 9
Montreal 9
Nürnberg 9
Paris 9
Fairfield 8
Guangzhou 8
London 8
Poplar 8
San Francisco 8
San Jose 8
Ankara 7
Chicago 7
Falls Church 7
Rio de Janeiro 7
Seattle 7
Stockholm 7
Toronto 7
Atlanta 6
Baku 6
Des Moines 6
Guarulhos 6
Johannesburg 6
Charlotte 5
Curitiba 5
Guayaquil 5
Jinan 5
Lima 5
Ningbo 5
Querétaro 5
Santa Clara 5
Secaucus 5
Auburn Hills 4
Brasília 4
Brooklyn 4
Falkenstein 4
Lanzhou 4
Las Vegas 4
Mexico City 4
Rome 4
Zhengzhou 4
Amman 3
Belo Horizonte 3
Borås 3
Buenos Aires 3
Campos dos Goytacazes 3
Can Tho 3
Columbus 3
Cuiabá 3
Detroit 3
Dhaka 3
Totale 4.718
Nome #
A novel splicing mutation causes an undescribed type of analbuminemia. 135
Analbuminemia in a Slovak Romany (gypsy) family: Case report and mutational analysis. 133
Molecular Genetics of Analbuminemia 132
A two-base-pairs deletion in the albumin gene causes a new case of analbuminemia. 131
A novel frameshift deletion in the albumin gene causes analbuminemia in a young Turkish woman. 120
Structural analysis, fatty acid and thyroxine binding properties of Vancouver and Naskapi variants of human serum albumin. 119
A novel splicing mutation causes analbuminemia in a Portuguese boy. 119
Structural caracterization of the oligosaccharide chains of human a1-microglobulin from urine and amniotic fluid. 110
Structural analysis and fatty acid binding properties of two Croatian variants of human serum albumin. 110
A novel two bases deletion in the albumin gene causes analbuminaemia in a young turkish man. 110
A new proalbumin variant: albumin Jaffna (-1Arg--->Leu) 106
Analbuminemia in a Swiss family is caused by a C --> T transition at nucleotide 4446 of the albumin gene. 106
The molecular defect of Albumin Tagliacozzo: 313Lys--->Asn. 105
Analbuminemia produced by a novel splicing mutation 104
A new bisalbuminemia: bisalbuminemia of Kenitra 104
Analysis of human serum albumin variants by mass spectrometric procedures. 102
Analbuminemia in a Swedish male is caused by the Kayseri mutation (c228_229delAT) 102
A novel nonsense mutation in the albumin gene (c.1275 C>A) causing analbuminemia in a Tunisian boy. 102
A genetic variant of albumin (albumin Asola; Tyr140-->Cys) with no free -SH group but with an additional disulfide bridge. 101
An active site-tyrosine-containing heptapeptide from D-amino acid oxidase. 101
A structural study of pig liver glyceraldehyde-3-phosphate dehydrogenase. 101
Mutations and polymorphisms of the gene of the major human blood protein, serum albumin 99
Analysis of human serum albumin variants by mass spectrometric procedures. 99
A novel mutation in the albumin gene (c.1A>C) resulting in analbuminemia. 99
Analbuminemia Zonguldak: case report and mutational analysis. 98
MOLECULAR DEFECTS IN GENETIC VARIANTS OF HUMAN SERUM ALBUMIN 97
A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. 97
Novel nonsense mutation causes analbuminemia in a Moroccan family. 95
Albumin Benkovac (c.1175 A > G; p.Glu392Gly): a novel genetic variant of human serum albumin. 93
Binding and relaxometric properties of heme complexes with cyanogen bromide fragments of human serum albumin 92
A novel frame-shift deletion causing analbuminaemia in an Italian paediatric patient. 91
Congenital analbuminemia caused by a novel aberrant splicing in the albumin gene 91
Human alpha-1-Microglobulin is Covalently Bound to Kynurenine Derived Chromophores 90
The amino acid substitution in albumin Roma: 321 Glu----Lys. 87
A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. 87
MODIFIED HIGH_AFFINITY BINDING OF NICKEL; CALCIUM AND ZINC TO NATURAL MUTANTS OF HUMAN SERUM ALBUMIN AND PROALBUMIN 86
Molecular diagnosis of analbuminemia: A novel mutation identified in two amerindian and two Turkish families 86
D-amino acid oxidase primary structure: cyanogen bromide fragments and sequences of the cysteynyl peptides 86
STRUCTURAL CHARACTERIZATION OF TWO GENETIC VARIANTS OF HUMAN SERUM ALBUMIN 85
Structural characterization of a chain termination mutant of human serum albumin. 85
Genetic variation in human serum albumin: a 313 Lys-->Asn mutation in albumin reading identified by PCR analysis. 85
Genetic variants showing apparent hot-spots in the human serum albumin gene. 84
Enzymatic properties of human hemalbumin. 84
Identification of the amniotic fluid insulin-like growthfactor binding protein-1 phosphorylation sites andpropensity to proteolysis of the isoforms 83
The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant. 83
Structural and biochemical characterization of a new type of lectin isolated from carp eggs. 83
A nucleotide deletion and frame-shift cause analbuminemia in a Turkish family. 82
High-performance liquid chromatography of complex mixtures of cyanogen bromide-produced peptides from different proteins. 81
Isolation, characterization and partial sequence of cyanogen bromide fragments and thiol peptides from pig kidney D-amino-acid oxidase. 81
Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid. 81
Separation of cyanogen bromide fragments from normal and abnormal human serum albumin by reversed-phase high-performance liquid chromatography. 80
Structural characterization of four genetic variants of human serum albumin associated with alloalbuminemia in Italy. 79
A novel splicing mutation in the albumin gene (c.270+1G>T) causes analbuminaemia in a German infant 77
The molecular defect in a COOH-terminal-modified and shortened mutant of human serum albumin. 76
Molecular diagnosis of analbuminemia: a new case caused by a nonsense mutation in the albumin gene. 76
structural characterization of the subunits of spinach chloroplast glyceraldehyde-3-phoshate dehydrogenase (NADP). 73
Amino acid sequence around the pyridoxal 5'-phosphate binding sites of 6-phosphogluconate dehydrogenase. 72
Localization of the amino acid substitution site in a fast migrating variant of human serum albumin. 71
MUTATIONS IN THE GENE OF HUMAN SERUM ALBUMIN: MOLECULAR AND FUNCTIONAL CONSEQUENCES AND THERAPEUTIC POSSIBILITIES 71
TWO ALLOALBUMINS WITH IDENTICAL ELECTROPHORETIC MOBILITY ARE PRODUCED BYDIFFERENTLY CHARGED AMINO ACID SUBSTITUTIONS 70
PROTEIN AND DNA SEQUENCE ANALYSIS OF A PRIVATE GENETIC VARIANT: ALBUMIN ORTONOVO (Glu 505--Lys) 70
Hormone binding to natural mutants of human serum albumin. 69
MUTATIONS IN GENETIC VARIANTS OF HUMAN SERUM ALBUMIN FOUND IN ITALY 69
Structural characterization and fatty acid binding properties of two French genetic variants of human serum albumin. 68
High-affinity binding of laurate to naturally occurring mutants of human serum albumin and proalbumin. 68
Effect of genetic variation on the fatty acid-binding properties of human serum albumin and proalbumin. 68
The molecular defect of albumin Castel di Sangro: 536 Lys----Glu. 67
Human serum albumin isoforms: genetic and molecular aspects and functional consequences. 66
Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. 65
Structural characterization of three genetic variants of human serum albumin modified in subdomains IIB and IIIA. 65
Reactivity of D-amino acid oxidase with 1,2-cyclohexanedione: evidence for one arginine in the substrate-binding site. 60
Structural characterization, stability and fatty acid-binding properties of two French genetic variants of human serum albumin. 60
Mutants and molecular dockings reveal that the primary L-thyroxine binding site in human serum albumin is not the one which can cause familial dysalbuminemic hyperthyroxinemia 59
Proceedings: Pyridoxal-phosphate-binding sites of 6-phosphogluconate dehydrogenase. 59
Isolation and characterization of a new form of the porcine pancreatic secretory trypsin inhibitor. Biochemical studies and high-resolution 1H-NMR 58
Molecular heterogeneity of ferredoxin-NADP+ reductase from spinach leaves. 58
Congenital Analbuminemia in Unrelated Algerian and Turkish Families is Caused by the Same Molecular Defect in the Albumin Gene. 58
High-affinity binding of warfarin, salicylate and diazepam to natural mutants of human serum albumin modified in the C-terminal end. 57
GENETIC VARIANTS OF HUMAN SERUM ALBUMIN: MOLECULAR AND FUNCTIONAL ASPECTS AND THERAPEUTIC POSSIBILITIES 57
The primary structure of D-amino acid oxidase from pig kidney. II. Isolation and sequence of overlap peptides and the complete sequence. 54
Purification and characterization of yeast thioredoxin reductase 53
Genetic variants of human serum albumin: molecular defects and biological stability. 53
Congenital analbuminaemia: molecular defects and biochemical and clinical aspects. 52
Radioimmunoassay and chemical properties of glucose 6-phosphate dehydrogenase and of a specific NADP(H)-binding protein (FX) from human erythrocytes. 51
Clinical, genetic, and protein structural aspects of familial dysalbuminemic hyperthyroxinemia and hypertriiodothyroninemia 50
Analbuminemia: three cases resulting from different point mutations in the albumin gene. 48
The primary structure of D-amino acid oxidase from pig kidney. I. Isolation and sequence of the tryptic peptides. 48
ANALBUMINEMIA: MOLECULAR ASPECTS AND CLINICAL CONSEQUENCES 47
Separation of fragments from human serum albumin and its charged variants by reversed-phase and cation-exchange high-performance liquid chromatography. 44
Totale 7.369
Categoria #
all - tutte 31.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.677


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021289 0 0 0 0 0 0 4 93 12 88 80 12
2021/2022342 4 14 2 7 5 4 9 25 19 14 58 181
2022/20231.343 124 98 5 124 154 121 0 87 574 8 30 18
2023/2024420 39 91 5 27 37 117 3 27 2 16 35 21
2024/20251.075 31 107 30 37 19 33 23 69 272 20 161 273
2025/20261.553 191 241 305 315 364 136 1 0 0 0 0 0
Totale 7.369